Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy
Phase II Trial on the Safety and Efficacy of Partial Cystectomy and Extended Pelvic Lymph Node Dissection With Standard of Care Perioperative Systemic Therapy in the Management of Muscle-Invasive Bladder Cancer (PRESERVE Trial)
Sponsor: Case Comprehensive Cancer Center
Listed as NCT06290687, this PHASE2 trial focuses on Malignant Neoplasm of Bladder and Muscle Invasive Bladder Carcinoma and remains actively recruiting participants. Sponsored by Case Comprehensive Cancer Center, it has been updated 7 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE2
-
Aug 2025 — Feb 2026 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2025 — Aug 2025 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2024 — Jun 2025 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE2
▶ Show 2 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Case Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .